Key Takeaways
- Margin-led quarter, not volume-led: EBITDA margin rose 3.6% to 11.6% while volume grew only ~2–3%, as own-plant utilization jumped 11 points and JVs swung from loss to profit.
- The JV turnaround is now real: JVs moved from a ₹10 crore loss to a ₹3 crore profit YoY, and management expects a full-year swing of more than ₹30 crores versus last year's ₹24–25 crore loss.
- Morbi's pain is Somany's gain: Morbi's 1.5-month shutdown, expensive Gujarat gas, and 50–60% export collapse have narrowed the price gap and cleared channel inventory, while 15–17% of Morbi capacity "is never going to start."
- Capacity expansion is the next leg: A new 9+ million sq m South plant (~₹220 crores, ~₹350 crores revenue potential) plus 0.4–0.5 crore sq m of line augmentation lands from mid-Q3 through Q4.
- What to watch next quarter: Whether the promised April sales catch-up materializes, whether Morbi's restart pressures pricing, and whether the construction chemicals capacity added in July actually moves the needle.
Margin Story: Utilization and JVs, Not Pricing
- Own-plant utilization is the core driver: Standalone utilization rose from 72% to 83% YoY, an 11-point jump that management calls a "major, major kicker to the EBITDA."
- JV swing is structural, not one-off: Last year's JV loss of ₹24–25 crores is expected to become a net profit this year, a swing of more than ₹30 crores.
- Somany Max losses narrowing: The loss fell from ~₹7 crores to ~₹1-point-something crore YoY, with management targeting ₹10 crores loss or less going forward.
- Pricing is explicitly not the margin story: Management says margins rose from operational efficiency and JV improvement, not pricing; pricing has only been a pass-through.
- Margin guidance may be raised: FY27 guidance was 100–150 bps above FY26; management says they are "absolutely" in position to increase it, contingent on utilization and mix.
Abhishek Somany: "My margins really have not gone up because of pricing. My margins have gone up because of operational efficiency that we are producing 100% in our own plants and also our JV losses have come down."
Morbi Dynamics: A Structural Shift in Somany's Favor
- The shutdown cleared the market: Morbi's 1.5-month closure caused Somany to miss a couple of percent of April sales, but it also cleared old channel stock and reduced the large inventory overhang from the past.
- The price gap has narrowed sharply: Morbi raised prices by more than double what Somany did, so Somany's landed dealer price versus Morbi has compressed.
- Fuel sourcing is now a Morbi problem: Morbi previously bought propane and LPG in "not the cleanest of ways"; switching to Gujarat gas forces them to rectify their books, further narrowing the gap.
- Permanent capacity exit: 15–17% of Morbi capacity that had not restarted by May has still not restarted, and management says it never will.
- Exports remain weak: Morbi exports are down 50–60% from peak on geopolitical and freight disruption, expected to continue this quarter.
Abhishek Somany: "15% to 17% of Morbi, which has not started is never going to start. That never started even in May, and that's not started even today."
Demand and Pricing Environment
- Demand is steady, not spectacular: May and June were "pretty decent," July "not bad" given rains; management is getting mid-single-digit volume growth, not high single-digit.
- Price increases are sticking: Prices had fallen 15–16% over 30 months, so the current increase has been well accepted; tile prices remain lower than five years ago even before inflation adjustment.
- Gas volatility is the wildcard: Gas prices rose every month, with June–July higher than May–June and August marginally higher again; all increases passed on so far.
- Channel is lean and cautious: Channel stocked up in March ahead of the Morbi shutdown, but has since normalized; dealers are holding back inventory because they expect gas prices to fall and trigger price reductions.
- Project business is a growth lever: Total project share (retail ~7–8% plus government ~10–11%) is expected to rise by about 3–4% in totality.
Abhishek Somany: "Pricing has only been a pass-through. I'm not earning anything from the pricing. So if it goes down, so be it. As long as I'm producing 100% and my JVs are profitable, this margin will sustain."
Capacity Expansion: The Next Growth Leg
- New South plant announced: A 9+ million sq m greenfield plant in the South, ~₹220 crores outlay, land already acquired, to be operational in 12–15 months with ~₹350 crores revenue potential.
- Existing line augmentation underway: 0.4–0.5 crore sq m being added across Bahadurgarh, Gujarat, Morbi, and South; ready from mid-Q3, fully in place by Q4.
- Construction chemicals capacity added: Large North capacity went on stream in July 2026; effects partly this quarter, mostly next quarter.
- JV value-add increases: One JV has taken a significant value-add increase via balancing equipment; most balancing work concludes by end of Q3.
- Revenue headroom: At current capacities and today's prices, maximum revenue is ~₹3,700 crores; bottleneck removal by year-end could add ~₹300 crores more, partly.
- Funding is internal: 65–70% of capex funded through internal accruals, not pressuring the balance sheet.
Abhishek Somany: "We are extremely confident of keeping our production -- our own production at 100% capacity utilization, which is a major, major kicker to the EBITDA."
Guidance Philosophy and Competitive Positioning
- Deliberate conservatism: Management admits past promises of high single-digit or low double-digit growth were never delivered, so they are now "very, very cautious" and will only commit to what they can deliver for sure: EBITDA margin and single-digit growth.
- Smaller players' growth is unsustainable: Management says smaller players' high growth is base-effect driven and "not sustainable," expecting it to play out from next quarter onwards.
- Margin trajectory is back-half loaded: Current margin will be held or slightly bettered until Q3–Q4, when all balancing equipment efforts take full effect.
- The peer margin gap went unanswered: When asked why the industry leader earns 18–19% margins versus Somany's ~11%, management deflected: "there's many, many areas of discussion. So maybe it's best we take it offline."
- Buyback request ignored: An analyst requested a share buyback citing market cap of ₹2,100 crores, EBITDA of 8–9, 50% below historical PE, and negative 5% stock CAGR over 5 years; management responded only "Thank you for your suggestion."
Abhishek Somany: "Various people have promised, including us in the past that we'll have high single-digit growth, low double-digit growth, but never has been delivered. So we have been very, very cautious in what we are saying, something which we will deliver for sure is our EBITDA margin and also our single-digit growth."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| April sales catch-up | Missed April volume "would be made up this quarter very handsomely" | Q2 FY27 |
| EBITDA margin | Maintain current 11.6% margin, then increase as quarters unfold | Hold through Q2–Q3, improve Q3–Q4 |
| EBITDA margin guidance | "Absolutely" in position to raise FY27 guidance above 100–150 bps over FY26 | FY27, contingent on utilization and mix |
| JV full-year swing | From ₹24–25 crore loss to net profit, swing >₹30 crores | FY27 |
| Somany Max loss | ₹10 crores loss or less | FY27 |
| Volume growth | Mid-single-digit volume growth | FY27 |
| South plant operational | 9+ million sq m plant, ~₹220 crores capex, ~₹350 crores revenue potential | End Q3 / beginning Q4 FY28 |
| Existing line augmentation | 0.4–0.5 crore sq m added across 4 locations | Ready mid-Q3, fully in place Q4 FY27 |
| Balancing equipment | Most concluded across JVs and wholly owned subs | End of Q3 FY27 |
| Revenue headroom | ~₹3,700 crores at current capacity; +₹300 crores partly from bottleneck removal | Year-end FY27 |
| Morbi export decline | Expected to continue until freight settles | This quarter |
Key Metrics
| Metric | Q1 FY27 |
|---|---|
| Sales volume growth | ~3% YoY, value grew 24% YoY |
| EBITDA margin | 11.6%, up 3.6 ppt YoY on capacity utilization and JV performance |
| Standalone capacity utilization | 83%, up from 72% in Q1 last year |
| JV profit/loss | Profit of ₹3 cr, versus loss of ₹10 cr in Q1 last year |
| Blended natural gas price | ~₹68, South and Morbi close to mid-70s, North around ₹68–₹69 |
| Price hike taken in Q1 | 16%–17% average |
| Morbi exports | Down 50%–60% from peak due to geopolitical reasons |
| Working capital days | 12 days, down from 17 days |
| Somany Max loss | ~₹1-point-something cr minus, versus ₹7 cr minus in Q1 last year |
| Volume growth guidance FY27 | Mid-single digits |
| Project business mix | 7%–8% retail, 10%–11% government, expected to go up 3%–4% in totality |
| Bathware and construction equipment margin | ~1% better than normal tile margins |
| New South plant capex | ~₹220 cr, operational end of Q3 or beginning Q4 of FY28, potential revenue ~₹350 cr |
| Total capex outlay to FY27 end | ~₹275 cr, funded 65%–70% through internal accruals |
| Maximum revenue at current capacity and prices | ~₹3,700 cr, give or take ₹50 cr |